Hidradenitis Suppurativa, Quality of Life
Conditions
Keywords
Hidradenitis Suppurativa, Quality of Life
Brief summary
The goal of this study is to get a better understanding of the impact of Hidradenitis Suppurativa (HS) on the quality of life of patients with this condition. Patients with HS will be asked questions about demographics including gender, age, and ethnicity. They will also be asked to complete questionnaires to determine how their skin condition affects their life. Study participation will last for 1 day, with potential for follow-up in the future. We hope this information will help us improve our treatment for this skin condition.
Detailed description
The goal of this study is to get a better understanding of the impact of the skin condition, Hidradenitis Suppurativa, on quality of life function of patients. Patients with HS will be asked questions about demographics including gender, age, and ethnicity. They will also be asked to complete questionnaires to determine how their skin condition affects their life. The questionnaires include Beck Depression Inventory form, which gives us information how you feel about your skin condition and how it changes your mood; Dermatology Life Quality Index (DLQI), which gives us information about how your skin condition affects your quality of life; Skindex, which gives us more specific information about how your skin condition affects your quality of life; SF-36 health survey, which gives us information about your general health status; the Quality of Life Enjoyment and Satisfaction Questionnaire- short form (Q-LES-Q-SF), which gives us information on your enjoyment and satisfaction of your life; and the Employment/Productivity Health Economic Questionnaire, which will give us more information on your work and school status as well as household income. Study participation will last for 1 day, with potential for follow-up in the future. Through potential follow up visits we hope to determine the longitudinal effect of treatment modalities on QoL through future survey performance of the patient cohort. We hope this information will help us improve our treatment for this skin condition.
Interventions
None listed
Sponsors
AbbVie
Montefiore Medical Center
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Inclusion criteria
* Clinical diagnosis of hidradenitis suppurativa * Subject age \>/= 18 years * Able to be evaluated by a Montefiore physician
Exclusion criteria
* No clinical diagnosis of hidradenitis suppurativa * Subject age \< 18 years * Subject unable to understand or answer provided questionnaires * Unable to evaluated by a Montefiore physician
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Employment and economic productivity | Baseline | Self-reported employment and economic productivity as measured by a standardized health economic questionnaire |
| Dermatology-related quality of life | Baseline | Quality of life as measured using standardized Dermatology Quality of Life Index |
| Presence and severity of depression | Baseline | Presence and severity of depression as measured using standardized Beck Depression Inventory |
| Subject-reported subject health | Baseline | Subject-reported subject health as measured using standardized SF-36 questionnaires |
| Degree of enjoyment and satisfaction experienced by subjects in daily functioning. | Baseline | Degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning as measured by the standardized Quality of Life Enjoyment and Satisfaction Questionnaire-short form. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in quality of life | At 6 months | Change in quality of life as measured using standardized Dermatology Quality of Life Index after treatment initiation |
| Change in presence and severity of depression as measured using standardized Beck Depression Inventory | At 6 months | Change in presence and severity of depression as measured using standardized Beck Depression Inventory after treatment initiation |
| Change in subject-reported subject health | At 6 months | Change in subject-reported subject health as measured using standardized SF-36 questionnaires after treatment initiation |
| Change in degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning | At 6 months | Change in degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning as measured by the standardized Quality of Life Enjoyment and Satisfaction Questionnaire-short form after treatment initiation |
| Change in self-reported employment and economic productivity | At 6 months | Change in self-reported employment and economic productivity as measured by a standardized health economic questionnaire after treatment initiation |
Countries
United States
Outcome results
None listed